Why the study?
Does extended-release niacin improve carotid intimal media thickness, endothelial function, and inflammatory markers in patients with metabolic syndrome?
Does extended-release niacin improve carotid intimal media thickness, endothelial function, and inflammatory markers in patients with metabolic syndrome?
Extended-release niacin therapy for 52 weeks regresses carotid intimal medial thickness, improves endothelial function, and reduces vascular inflammation in patients with metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Supports extended-release niacin for vascular benefits in metabolic syndrome; extends surrogate marker data to endothelial and inflammatory endpoints.
Thoenes et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: